GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Laboratory Corp of America Holdings (NYSE:LH) » Definitions » Forward Dividend Yield %

Laboratory of America Holdings (Laboratory of America Holdings) Forward Dividend Yield %

: 1.46% (As of Today)
View and export this data going back to 1991. Start your Free Trial

As of today (2024-04-18), the Forward Annual Dividend Yield of Laboratory of America Holdings is 1.46%.

As of today (2024-04-18), the Trailing Annual Dividend Yield of Laboratory of America Holdings is 1.46%.

LH's Forward Dividend Yield % is ranked worse than
58.9% of 73 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.07 vs LH: 1.46

Laboratory of America Holdings's Dividends per Share for the three months ended in Dec. 2023 was $0.72.

During the past 12 months, Laboratory of America Holdings's average Dividends Per Share Growth Rate was 33.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Laboratory of America Holdings was 74.70% per year. The lowest was -33.30% per year. And the median was 20.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison

For the Diagnostics & Research subindustry, Laboratory of America Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratory of America Holdings Forward Dividend Yield % Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Laboratory of America Holdings's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Laboratory of America Holdings's Forward Dividend Yield % falls into.



Laboratory of America Holdings Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Laboratory of America Holdings Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.7202024-02-262024-02-272024-03-13Cash DividendquarterlyUSD:USD 1.000000
USD 0.7202023-11-072023-11-082023-12-12Cash DividendquarterlyUSD:USD 1.000000
USD 0.7202023-08-072023-08-082023-09-08Cash DividendquarterlyUSD:USD 1.000000
USD 0.7202023-05-172023-05-182023-06-08Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Laboratory of America Holdings's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=2.88/199.45
=1.44 %

Current Share Price is $199.45.
Laboratory of America Holdings's Dividends per Share for the forward twelve months is calculated as $0.72 * 4 = $2.88.

Laboratory of America Holdings's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=2.88/199.45
=1.44 %

Current Share Price is $199.45.
Laboratory of America Holdings's Dividends per Share for the trailing twelve months (TTM) ended in Today is $2.88.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratory of America Holdings  (NYSE:LH) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Laboratory of America Holdings Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Laboratory of America Holdings's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratory of America Holdings (Laboratory of America Holdings) Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Executives
Peter J Wilkinson officer: SVP, Chief Accounting Officer C/O PHARMACEUTICAL PRODUCT DEVELOPMENT, 929 NORTH FRONT STREET, WILMINGTON NC 28401
Kerrii B Anderson director WENDY'S INTERNATIONAL, INC, 4288 WEST DUBLIN-GRANVILLE RD., DUBLIN OH 43017
Van Der Vaart Sandra D officer: SVP, Global General Counsel 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Paul Rothman director 6 MEADOW ROAD, BALTIMORE MD 21212
Paul R Kirchgraber officer: CEO, Covance Drug Development 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Mark S Schroeder officer: EVP, President-Diagnostics Lab 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Megan D. Bailey officer: EVP, Chief Strategy Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Jonathan P. Divincenzo officer: EVP, Pres, Central Labs & Intl 940 WINTER STREET, PERKINELMER, INC. LEGAL DEPARTMENT, WALTHAM MA 02451
Anita Z Graham officer: EVP, CHRO C/O THE ADT CORPORATION, 1501 YAMATO ROAD, BOCA RATON FL 33431
Thomas Pike officer: Pres & CEO Clinical Business C/O ACCENTURE, 161 N. CLARK STREET, 23RD FLOOR, CHICAGO IL 60601
Kirsten Marie Kliphouse director 531 SOUTH SPRING STREET, BURLINGTON NC 27215
Glenn A Eisenberg officer: Chief Financial Officer, EVP P O BOX 1017, CHARLOTTE NC 28201-1017
Brian J Caveney officer: SVP, Chief Medical Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215
R Sanders Williams director DUKE UNIVERSITY SCHOOL OF MEDICINE, TRENT DRIVE, DURHAM NC 27706
Amy B. Summy officer: EVP, Chief Marketing Officer 531 SOUTH SPRING STREET, BURLINGTON NC 27215